*****This thread is setup mainly to gain information
relating to Mediwatch in a quick and easy way and IS IN NO WAY A
RECOMMENDATION TO BUY!********


Mediwatch-A Synopsis:
Mediwatch was established in 1996 and has developed a range of specialist
medical equipment for the diagnosis of urological disorders.The group joined the
AIM in 2000 through a reverse into Prostcare plc,which at the time was valued at
8m.While the vast majority of sales were generated in the UK,there was a
substantial indirect export business involving a number of agents,supplying into
Europe,North America,Australasia and Asia,notably Japan.
Group revenues are set to increase rapidly following the acquisition of the former
Medtronic Urodynamis Division,which has introduced a fundamental presence in
North America.The deal was in 2006 with the sales division building from 2007.
With the inclusion of the Medtronic systems now owned by Mediwatch they now
can offer a 'One Stop Shop' for the diagnosis of various urology disorders with the
benefit of Mediwatch systems having the ability to electronically send data from the
various tests to a central data base!Oh and plus the added bonus of PSAwatch and
now PCA3plus!

More than 30 million PSA tests are performed annually in the USA alone!

CHARTS

FUTURE EVENTS AND LATEST
NEWS

Just for the record and to even things up,this is Treblewide's view (near end
of 2008):

"in short 3p by chrimbo and a real chance if they do not get rid of management they
will go into receivership.....when they bough the MDT business I said at the time it
must have been a bag of shite as they only paid buttons for it.......looks like that was
fairly correct......i feel sorry for shareholders"

Treblewide has been filtered from my eyes for his abuse,lies and general behavior but
it's a free country (I think) so do as you see fit.


It started with:

Treblewide - 05 Jun 2007 15:49 - 33 of 1747
still short

Treblewide - 18 Jun 2007 00:24 - 69 of 1747
interesting stuff from that article...very few men die from prosate cancer and it is not an agressive disease....treatment can be worse than the disease.......kind of suggests their whole business model is based on sand to me.......but hey who wants a balanced view.

Treblewide - 18 Jun 2007 00:31 - 76 of 1754
exercise and sex may cause a raised PSA...so you guys may have stumbled on a test for fit shaggers :-)

I am gonna name Me-Di-Watch

Gonna-go-bust-soon-iwatch

Treblewide - 18 Jun 2007 10:59 - 85 of 1754
minder...i do not make light of prosate cancer....show me one post where I do...i make fun out of this company yes but not the disease so wind yer neck in pal.

show me any trace of a profit and i will maybe change my mind

Treblewide - 18 Jun 2007 15:54 - 97 of 1754
minder made a small loss yes which I have more than made up for shorting it........and i guess your average holding is 3p.....aye right.

Aalso I closed out my short at 8p for a loss of the spread if memory serves me correctly.

currently short from 13.25....i thank you and goodnight

Treblewide - 23 Jul 2007 12:36 - 154 of 1747
more of the same......thank god i still do not own shares in this lot...will they ever
make a penny profit....looks doubtful......cannot even manage a small supply chain.


ect ect ect

with the last few posts:

Treblewide - 30 Mar 2009 09:16 - 1704 of 1754
you are a lunatic mick.....words fail me.

and ps i only post under treblewide on any financial web site....i know you cannot say the same......you have been calling this as a buy and nothing but a buy for about 7 years...it says it all really about your stock picking ability

i notice the downtrend ins now establishing itself....re-visit of the lows again by the looks of things

Treblewide - 30 Mar 2009 22:41 - 1712 of 1754
mick no i dont know what each product does...i dont think that is important...the numbers tell everything and even though you must spend hours on web sites searching for stuff that is not even related to MDW you fail to grasp the basics...they consistently lost money and now seem to be making some...my call to 3p was correct and i think if they had not got their shit together they could have gone under

i was not interested in them as a long play while they were loosing money depsite whatever rubbish you posted regarding piss sticks or whatever you bang on about.

and yes it was poor trading..having an avergae of 12 and averaging down to 6-7p while they were at 3p....is terrible trading...that cannot even be debated...the very fact you know so much about the products means you have fallen in love with this company......which is very dangerous when investing....

the numbers are the important things...i was right on 3p, the company is posting slightly better figures but we are in a bear market which has not bottomed yet so the price will fall further

you are a 1 trick pony that posts irrelevant links...dont bother to respond i can be bothered getting into a debate with you.....away and cut and paste some more flags

toodlepip

**************************************************************

I have been chased from here and now ADVFN,has the boy got a problem?

treblewide - 3 Aug'09 - 14:46 - 22345 of 22412


post 22342 is classic.....so mick advfn is not a good source when the consensus is sell?

begs the question why you spend so much time polluting it with your bull tripe?

question....so MDW share price has gone up, it has gone down etc etc...during all of that time has mick ever been able to find any subjectivity in his posting ie has he ever critisised anything?

i really think he may be getting paid by MDW...the whole thing is very bizzare.

mick i notice you referred to your threads as "promotion of Mediwatch"

can you confirm if you are getting financially rewarded by the company for this?

treblewide - 3 Aug'09 - 23:55 - 22371 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....



treblewide - 4 Aug'09 - 00:19 - 22373 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....

treblewide - 4 Aug'09 - 10:49 - 22379 of 22412


still time to get out at 6p.....dont understand why you would not sell at 6p when they are obviously going to half in value...if you are a long term mdw bull you can buy twice as many shares at 3p and maybe possibly one day see a profit on your holding?



treblewide - 4 Aug'09 - 12:44 - 22381 of 22412


last chance to sell at 6p for your shares folks


treblewide - 4 Aug'09 - 14:48 - 22387 of 22412


so question...is psawatch is so great...why has there been no huge surge in revenue figures from UK and Europe on the back of it being sold?

the whole reason a lot of you hold this is psawatch...it has not made them any money in Europe which could be argued when taken as a whole is not much smaller than the USA.....this company is not going to change overnight with US approval...at bets it would be a selling opportunity for long term holders

i really think a lot of you have to ignore some of the nonsense ramping going on here...the company is draining cash and there margins are reducing (despite this wonder PSA machine they have for sale)

i really think the future looks bleak for mediwatch...if someone can put in concise terminology why MDW is a buy i am all ears....dont point me at fairfax report...they are a bunch of clowns as well...that interim report is shocking and i mean really poor.

costs out of control...margins squeezed, cash running out...no real revenue growth, does this sound like a growth company to you?

sell at 6p


treblewide - 4 Aug'09 - 15:50 - 22391 of 22412


god i have heard it all now...mick can you counter my points about declining margins and cash issues without nonsense posts about peopel having insider information...what a crock and what a clown.

so just so i have this straight in my head...when you put in effort to ramp these shares it is all great and you expect cuddles? (and if anyone disagrees you throw your toys out the pram liek an old woman)

when i put up a few posts to explain why i am short it is an organised attempt to get the share price down because i have insider inforamtion from the US?

were you the Iraqi information minister in a previous role? lol


treblewide - 5 Aug'09 - 19:24 - 22409 of 22412


lol.....shares getting sold today at 5.75.....next stop 3p...

treblewide - 4 Aug'09 - 12:44 - 22381 of 22408 edit


last chance to sell at 6p for your shares folks




treblewide - 5 Aug'09 - 19:29 - 22410 of 22412


i wonder what thier overdraft is limited to....1M?

if so they have 12 months of life left at current perfomance...how many of you hlders have considered the chances of them going bust?....i would not rule it out...would love to know how much further the banks will let them go into debt before they pull the plug

treblewide - 5 Aug'09 - 19:37 - 22411 of 22412


seriously if i were a holder i would look at the interims and ask how much longer can they go on burning cash.......and with all the averaging down the bulls have done over the years i bet some are more exposed than they should be....good luck...think you might need it




ANYWAY

http://mediwatch.blogspot.com/

Another distributor,AVF Perimedical?

France,with at least four MDW products showing:


http://www.avf-perimedical.com/matrielurologie-c-28_160.html?osCsid=8ad

Good afternoon Banjo, I don't know how you find it all!
It's been a dull boring time with MDW but now looks like things are going to hot up.
Results early Jan I believe so could become active very soon.....keep digging :-)

Afternoon Opto,It's called using a search engine..........I believe. :-)

If the Final Results are due in January then yes volume should pick up and when combined with the latest USA announcement (with more to follow-imo) we may even see a whooosh!

Re ACP announcement-'additional Mediwatch products as developed.'

and 'As a company, we have taken a strategic decision to partner with Mediwatch in the long term care market as they have a track record for innovation and product quality, and will develop unique products in conjunction with ACP':




"The range of diagnostic equipment supplied by Mediwatch to ACP for the US market
will include a customised version of the Portascan which will include
cystometry, ultrasonic imaging and uroflow along with additional Mediwatch
products as developed.

ACP's Chief Technology Officer Dr. Chris Castel welcomed the opportunity to work
cooperatively with Mediwatch.

He said: 'Urinary Incontinence is a significant cause of suffering in the
elderly population. We have chosen Mediwatch's equipment for its excellent
design, portability and ease of use by our clinicians. As a company, we have
taken a strategic decision to partner with Mediwatch in the long term care
market as they have a track record for innovation and product quality, and will
develop unique products in conjunction with ACP, targeted towards the diagnosis
and management of incontinence in the elderly.'"

In my opinion we should class the recent USA deal as a pivotal turning point, not for MDW as that occurred earlier this year but for share holders both present and future.

As said before the MDT deal was massive and a major undertaking for any company to restructure,reinvent,increase distribution map and intwine both companies products into a one product band,sorry brand (been playing me banja)

So,with that said here is what MDW do and an explanation of the main fields they cover:

"Mediwatch has developed a range of medical equipment for the diagnosis of a variety of clinical conditions. Mediwatch focuses it's design skills on unique diagnostic products that can be used with simplicity, across the medical profession, by healthcare providers with different levels of clinical expertise.

Mediwatch's research and development strategy draws on extensive clinical knowledge with a seamless interface between the point-of-care and innovation with cutting-edge technology."

Urology

Urology is the study and treatment of diseases of the urogenital tract. Awareness of urological disorders and patient-specific disease management is increasing with on-going advances in the quality and specificity of diagnostic testing.

Diagnostic Ultrasound

Diagnostic ultrasound is the use of ultrasonic or high-frequency sound waves to produce images of the internal organs of the body specifically for diagnostic purposes. Diagnostic ultrasound is a painless, non-invasive imaging technique.

Urodynamics

Urodynamics is the investigation of the function and dysfunction of the lower urinary tract. Urodynamic studies involve the measurement of pressure, flow or electrical activity of the lower urinary tract.

Point-of-care Biochemistry

Point-of-care clinical tests utilise blood, body fluids or secretions in biochemical reactions to diagnose or monitor a variety of medical conditions.

Website updated with the new ACP deal,not earth shattering news but news all the same! :-)

and another one..........


Mediwatch plc
('Mediwatch' or 'the Company')
Strategic Relationship Established Between
Mediwatch and Device Technologies


To address the rapidly growing requirement for long-term care of the elderly in
Australia and New Zealand, Mediwatch Plc ('Mediwatch') (AIM: MDW), the
innovative medical equipment manufacturer, has signed a contract to supply a
comprehensive range of diagnostic urological products to leading Australian
medical devices company Device Technologies Pty. Ltd. ('Device Technologies').

The range of diagnostic equipment supplied by Mediwatch to Device Technologies
for the Australian and New Zealand market will include: Portascan+(TM),
Multiscan(TM), Portaflow(TM), Urodyn 1000(TM), Duet LogicTM, Duet Encompass(TM),
Sensic G3(TM)

The five year sales deal is estimated to be worth in the region of 3 million
over the contract period. The deal follows the recent announcement (Thursday 22
November 2007) of a two year sales contract with Accelerated Care Plus Corp with
an estimated worth of at least 2 million.

Morning petralva,
All looking rather good :-)

all we need now is fda approval for psa...............and off we go.

Device Technologies is an independent, privately-owned Australian company. Established in 1992, it employs 250 people in Australia and New Zealand and operates sales offices in every Australian state and in Auckland, New Zealand.


"It markets and sells high quality capital equipment and medical device consumables. Products are imported from the USA and Europe as well as being locally manufactured.

Our independent status enables us to be selective in the products we distribute, the services we provide and the people we employ."



"Company Mission Statement

To supply cost effective and technologically innovative products to Australian healthcare clients using professionally superior sales distribution and service facilities.

Device Technologies is committed to quality. Quality of product and service is our goal. We aim to achieve this through our quality management system (AS/NZS ISO 9001), as well as our marketing, sales, customer service, purchasing, warehousing, regulatory and distribution divisions.

We provide the medical and surgical staff of the Public and Private Healthcare Institutions with advanced education and superior technical support and customer service, as well as the latest clinical research data internationally available."


Device Technologies

bloody hell some contracts...only about 1.3M per annum between the two so not exactly world changing but interesting for the bulls

Not even a good evening,comes in cursing,where are your manners,Treble?


:-)

apologies :-) morning Mick

TW, The capitalisation of company is about 14.6 million. The over all "promised contracts" in comparison are more than reasonable for a developing company in their area.

indeed it is interesting but at just over 1M per year it is not huge especially with the large increase in overheads they are carrying after MDT acquisition and losses they still make

but as i said at last some encouragement for the bulls instead of blind hope

That's much better,Treble and afternoon :-)

Can't stop,busy busy! 'blind hope'-lol

Just resting today :-)

Cancer Reform Strategy
Document type: Guidance Author: Department of Health
Published date: 3 December 2007
Primary audience: Health and social care professionals

http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_081006

The Cancer Reform Strategy builds on the progress made since the publication of the NHS Cancer Plan in 2000 and sets a clear direction for cancer services for the next five years. It shows how by 2012 our cancer services can and should become among the best in the world.


From mdrans1 post and link some key points relating to just to the PSA test,imo:


"3.38 The Prostate Cancer Risk Management Programme (PCRMP) was introduced in 2002 to help GPs and practice nurses in advising men
without symptoms of prostate cancer on the implications of having a PSA test."

"A consultation will be published in the spring,with the intention of launching the revised PCRMP packs in the summer of 2008. The review will take full account of the results of the Prostate Cancer in Ethnic Subgroups (PROCESS)
study22, which showed that black men are three times more likely to develop prostate cancer compared to white men."


"3.50 However, there are several notable examples of awareness campaigns and pilot programmes to encourage help-seeking behaviour:"

"● A pilot programme in Coventry funded by the Department of Health and signatories to the Prostate Cancer Charter for Action aimed to raise awareness of the prostate and its function, including among Afro-Caribbean men, using community health promotion techniques in pubs, clubs and workplaces;"


"CHAPTER 7: DELIVERING CARE IN THE MOST APPROPRIATE SETTING

7.13 GPs with a special interest in cancer may wish to develop and offer particular diagnostic services under practice based commissioning.During the development of this strategy stakeholders told us that models which may develop and will need to be evaluated include:

● Community-based Prostate Health Clinics
(see Box 35 below)"

"Box 35: Community-based Prostate Health Clinics

Due to the complexities involved in diagnosing significant prostate cancers, one suggested model is that men should receive advice and support on prostate health issues at dedicated community-based prostate health clinics. Decision advisers would help men at the following points in the pathway:

● Men without symptoms considering having a PSA test or equivalent;
● Men with urinary or other potential symptoms of prostate cancer;
● Men considering having a biopsy for prostate cancer following a PSA test; and
● Men diagnosed with benign prostate disease.

Decision advisers could be clinical nurse specialists (CNSs) on a dedicated or outreach basis,GPs with a special interest in prostate cancer, community based specialist urologists or other appropriately trained practitioners. Access to prostate health clinics would be via GP referral or direct access for men concerned about their prostate health.Improved support for men in making decisions about further investigation or treatment would not be a form of rationing, but rather a way of ensuring that men have the best possible information and support when making difficult decisions. Improved support for men will ensure
that more appropriate referrals for biopsy or further care will be made"


Also:

"34. GPs and primary care professionals must have quick and easy access to relevant diagnostic tests, both to exclude cancer in patients with a low chance of having cancer and to diagnose cancer quickly in patients with a high chance of having cancer."

http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_081013

SynMed:


Medical Distributors Europe

The SynMed International Distributor Network consists of several leading European Independent distributors of medical diagnostic equipment covering areas of Gastroenterology, Urology and Neurodiagnostics.

Each company specializes in the supply service and support of GI supplies to medical professionals in their respective countries. The groups members share similar ethos and values and meet together with manufacturers throughout the year.



The SynMed group works together to:
Source quality products for their respective markets
Share expertise and knowledge
Provide combined support to customers in Europe


Medical Equipment manufacturers benefit by:
Having access to a one stop channel for your products
Speeding up time to market
Working with the leaders in their respective fields


http://www.synectics.se/flodesmatare.asp


http://www.synectics.se/urodynamik.asp


http://www.synectics.se/Blasskanner.asp

The SynMed Group:

http://www.synectics.se/synmedgroupmembers.asp